Qube Research & Technologies Ltd

Position in DYN — Dyne Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in DYN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,589,663

-$3,477,663 QoQ

Shares Held

253,153

-38.6% QoQ

Ownership

0.177%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,033,804,065 across 186 Biotechnology names. DYN ranks #77 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,589,663	253,153	-38.6%	Shares	Sole	2026-05-15
2025-12-31	$8,067,326	412,440	-50.3%	Shares	Sole	2026-02-17
2025-09-30	$10,496,577	829,769	+4.8%	Shares	Sole	2025-11-14
2025-06-30	$7,539,716	791,987	+16.3%	Shares	Sole	2025-08-14
2025-03-31	$7,121,544	680,836	+154.6%	Shares	Sole	2025-05-15
2024-12-31	$6,299,402	267,377	+1054.2%	Shares	Sole	2025-02-14
2024-09-30	$832,122	23,166	-77.0%	Shares	Sole	2024-11-14
2024-03-31	$2,857,623	100,656	+88.7%	Shares	Sole	2024-05-14
2023-12-31	$709,475	53,344	+200.9%	Shares	Sole	2024-02-13
2023-03-31	$204,203	17,726	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.